NasdaqGS:ZVRAPharmaceuticals
Is Zevra Therapeutics (ZVRA) Pricing Reflect Its Strong DCF Upside Potential
If you are wondering whether Zevra Therapeutics is attractively priced or already reflects its potential, the starting point is to understand how the current share price compares to a range of valuation measures.
The stock closed at US$8.98, with returns of 0.6% over the last 7 days, 0.4% over 30 days, 7.7% year to date and 10.9% over 1 year. Over 3 years the return is very large at around 2x, while the 5 year return is a 4.4% decline.
Recent news coverage around Zevra has focused on its...